Meridian Bioscience

Meridian Bioscience Dividend Coverage

The Dividend Coverage Ratio of Meridian Bioscience (VIVO) as of Oct 26, 2026 is 4.55. In the previous year, Dividend Coverage Ratio was 1.11 — a change of 309.13% (higher).

Dividend Coverage

4.55

YoY

309.13%

Last updated:

Dividend Coverage Ratio of Meridian Bioscience is 2019 4.55 . Dividend Coverage Ratio of Meridian Bioscience was 2018 1.11 . It decreases by 309.13% higher compared to the previous year.

The Meridian Bioscience Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2014
1.04 USD
Jan 1, 2015
1.06 USD
Jan 1, 2016
0.95 USD
Jan 1, 2017
1.01 USD
Jan 1, 2018
1.11 USD
Jan 1, 2019
4.55 USD
The Meridian Bioscience Dividend Coverage history
YEARDividend CoverageYoY
4.55+309.13%
1.11+9.67%
1.01+6.83%
0.95-10.15%
1.06+2.06%
1.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Dividend Coverage Ratio of Meridian Bioscience is 4.55 in 2019.

Dividend Coverage Ratio of Meridian Bioscience changed from 1.11 to 4.55, representing a 309.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Meridian Bioscience

All Key Metrics — Meridian Bioscience